Copyright
©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 21, 2006; 12(7): 1071-1077
Published online Feb 21, 2006. doi: 10.3748/wjg.v12.i7.1071
Published online Feb 21, 2006. doi: 10.3748/wjg.v12.i7.1071
Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity
Osamu Kanauchi, Masanobu Fukuda, Kirin Brewery Co. Ltd., 10-1-2 Shinkawa Chuo-ku, Tokyo, 104-8288, Japan
Yoshiaki Matsumoto, College of Pharmacy, Nihon University; 7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan
Shino Ishii, Toyokazu Ozawa, Makiko Shimizu, Department of Clinical Pharmacology and Toxicology, Showa Pharmaceutical University, 3-3165, Higashi- Tamagawagakuen, Machida, Tokyo, 194-8543, Japan
Keiichi Mitsuyama, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
Akira Andoh, Shiga University of Medical Science, Tsukinowa, Seta, Otsu, Shiga, 520-2100, Japan
Correspondence to: Osamu Kanauchi, Kirin Brewery Co. Ltd., 10-1-2 Shinkawa Chuo-ku, Tokyo 104-8288, Japan. kanauchio@kirin.co.jp
Telephone: +81-3-5541-5873 Fax: +81-3-5541-5874
Received: March 10, 2005
Revised: July 2, 2005
Accepted: August 26, 2005
Published online: February 21, 2006
Revised: July 2, 2005
Accepted: August 26, 2005
Published online: February 21, 2006
Core Tip